Nobilis Health Corp. announced that the previously issued consolidated financial statements covering the company's fiscal year ended December 31, 2014 and the consolidated financial statements for the fiscal quarters ended March 31, 2015 and June 30, 2015 (collectively, the "Restatement Reports") that was declared effective on October 27, 2015, require restatement and should no longer be relied upon. Accordingly, investors should no longer rely upon the company's previously-issued financial statements for these periods, any earnings releases relating to these periods, the auditors' reports on those financial statements, and management's report on the effectiveness of the company's internal control over financial reporting as of December 31, 2014.

The company intends to amend the Restatement Reports to correct the errors and file them with the Securities and Exchange Commission as soon as possible. The financial statements for the Restatement Reports contain errors related to (1) accounting for warrants and options issued in the company's private placements in 2013, 2014 and 2015 and options granted to non-employees; (2) business combination accounting with respect to the Athas and First Nobilis transactions that occurred in December and September 2014, respectively; (3) reclassification of contingently redeemable non-controlling interests to temporary equity; (4) share-based compensation matters; and (5) calculations of fully diluted shares outstanding for application of the treasury stock method. Based on management's preliminary assessment to date, the company does not believe there will be any significant changes in revenue or adjusted EBITDA for the periods covered by the Restatement Reports, except for approximately $700,000 in additional reported revenue and an anticipated minor positive impact on adjusted EBITDA for the three months ended March 31, 2015 and the six months ended June 30, 2015.